Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit

HIV Medicine

Volumn 7, Issue 3, 2006, Pages 193-196

  Palacios, Rosario ^a   Hidalgo, A ^a   Reina, C ^a   de la Torre, M V ^a   Marquez M ^a   Santos, J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

AIDS; HIV infection; In hospital mortality; Intensive care; Pneumocystis jiroveci pneumonia

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DEATH; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LACTIC ACIDOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SURVIVAL RATE; TOXOPLASMOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; PATIENT ADMISSION; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS;

EID: 33644778736     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00353.x     Document Type: Review

References (14)

1. Palelle FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
2. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-1730.
3. Santos J, Palacios R, Gutiérrez M et al. HIV infection in the era of highly active antiretroviral therapy. The Malaga Study. Int J STD AIDS 2004; 15: 594-596.
4. Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000; 118: 138-145.
5. Morris A, Creasman J, Turner J, Luce J, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002; 166: 262-267.
6. Leifeld L, Rockstroh J, Skaide S et al. Indication, outcome and follow up of intensive care in patients with HIV-infection. Eur J Med Res 2000; 5: 199-202.
7. de Palo VA, Millstein BH, Mayo PH, Salzman SH, Rosen MJ. Outcome of intensive care in patients with HIV infection. Chest 1995; 107: 506-510.
8. Gill JK, Greene L, Miller R et al. ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey. Anaesthesia 1999; 54: 727.
9. Morris A, Wachter RM, Luce J, Turner J, Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003; 17: 73-80.
10. Masur H. Acquired immunodeficiency syndrome in the intensive care unit. Will human immunodeficiency virus-related admissions continue to decline? Am J Respir Crit Care Med 2002; 166: 258-261.
11. Nuesch R, Geigy N, Schaedler E, Battegay M. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21: 684-687.
12. Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004; 18: 1429-1433.
13. Bonarek M, Morlat P, Chêne G et al. Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units. Int J STD AIDS 2001; 12: 239-244.
14. Wachter RM, Luce JM, Hopewell PC. Critical care of patients with AIDS. J Am Med Assoc 1992; 267: 541-547.